HSA
MGNX icon

Hussman Strategic Advisors’s MacroGenics MGNX Stock Holding History

Hussman Strategic Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,000
Closed -$214K – 274
2018
Q3 		$214K Buy
+10,000
New +$213K 0.06% 152

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Hussman Strategic Advisors's MGNX Position: Q4 2018 in Review

Hussman Strategic Advisors sold out of MacroGenics (MGNX) in Q4 2018, closing a stake of 10,000 shares — an estimated $214K sold.

Hussman Strategic Advisors first reported a position in MGNX in Q3 2018 and held it in 1 quarter. The position peaked at $214K in Q3 2018. 133 funds tracked by Wall St. Rank hold MGNX as of Q4 2018.

  • Hussman Strategic Advisors reported no remaining MacroGenics position as of Q4 2018 after selling out during the quarter.
  • Hussman Strategic Advisors sold 10,000 MacroGenics shares in Q4 2018, an estimated $214K.
  • Hussman Strategic Advisors first reported a position in MacroGenics in Q3 2018 and held it in 1 quarter.
  • Hussman Strategic Advisors's MacroGenics position peaked at $214K in Q3 2018.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q4 2018.

Based on Hussman Strategic Advisors's 13F filing for Q4 2018, filed 1 Feb 2019.